ISPOR 11th European Congress AWARDS WINNERS

By Stephen Priori, Director, ISPOR Publications

The ISPOR Best Research Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, and Asia-Pacific Conferences. At this year's European Congress, the ISPOR Awards Committee evaluated approximately 76 podium presentations and over 900 poster presentations.

Evaluations of scientific merit were based upon the following criteria:

Background provides appropriate perspective / context for the subject
Objectives / research questions are clearly stated
Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
Data sources and/or sampling procedures are clear and appropriate
Data analyses are appropriate
Research objectives are met/addressed
Implications of findings are discussed
Factual information is kept separate from interpretations or implications
Abstract is presented in an unbiased manner
Clarity of presentation

THE RECIPIENTS ARE: . . .

ISPOR Best Poster Research Presentation Awards

HT3
A COMPARISON OF REASONS FOR RECOMMENDATION AND REJECTION IN FOUR HEALTH TECHNOLOGY APPRAISAL SYSTEMS: NICE, SMC, CADTH AND PBAC
Cann K, Karia R, Plested M, Samuels E, Zwaferink H

Heron Evidence Development Ltd, Letchworth Garden City, UK

MO2
INCORPORATING CALIBRATED MODEL PARAMETERS INTO SENSITIVITY ANALYSES: DETERMINISTIC AND PROBABILISTIC APPROACHES
Taylor DC¹, Kruzikas D², Pawar V³, Gilmore K¹, Naik S¹, Weinstein MC⁴
1i³ Innovus, Medford, MA, USA, ²GlaxoSmithKline, Philadelphia, PA, USA, 3Innovus Research, Inc, Medford, MA, USA, ⁴i3 Innovus Research Inc., Harvard School of Public Health, Harvard Medical School, Boston, MA, USA

MS3
POPULATION HEALTH-STATE UTILITIES FOR FIBROMYALGIA IN THE UK
Hauber AB¹, McCrink L², Beard S², Garcia-Cebrian A³, Maas G⁴, Das Gupta R⁵, Le TK⁶
¹RTI Health Solutions, Research Triangle Park, NC, USA, ²RTI Health Solutions, Manchester, UK, ³Eli Lilly and Company Limited, Basingstoke, UK, ⁴Boehringer Ingelheim GmbH, Ingelheim, Germany, ⁵Boehringer Ingelheim, Bracknell, Berkshire, UK, ⁶Eli Lilly and Company, Indianapolis, IN, USA

ISPOR Best New Investigator Podium Presentations Awards

	AR3 TO INVESTIGATE THE BENEFIT OF ANTI-TNF THERAPY ON PHYSICAL AND MENTAL FUNCTIONING VIA THE SHORT FORM-36 QUALITY OF LIFE QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS Adams R¹, Ng CT², Gibbs A³, Bresnihan B⁴, Veale D⁵, Tilson L¹, FitzGerald O5, Barry M1 ¹National Centre for Pharmacoeconomics, Dublin, Ireland, ²St.Vincents University, Dublin, Ireland, ³Galway Clinic, Galway, Ireland, ⁴St. Vincents University Hospital, Dublin, Ireland, ⁵St.Vincents University Hospital, Dublin, Ireland
	CN6 COST-EFFECTIVENESS OF A HUMAN PAPILLOMAVIRUS VACCINE IN REDUCING THE RISK OF CERVICAL CANCER IN IRELAND USING A TRANSMISSION DYNAMIC MODEL Usher C¹, Tilson L¹, Olsen J², Rudbeck Jepsen M³, Walsh C⁴, Barry M¹ ¹National Centre for Pharmacoeconomics, Dublin, Ireland, ²University of Southern Denmark, Odense, Denmark, ³Statens Serum Institut, DK-2300 Copenhagen S, Denmark, ⁴Trinity College Dublin, Dublin, Ireland
	MH2 THE SUSTAINED DIAGNOSIS OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER FROM CHILDHOOD TO ADULTHOOD: A MEDICAID STUDY Chen H, Sudharshan L University of Houston, Houston, TX, USA

ISPOR Best Student Podium Research Presentations Awards

MH7
PATIENT REPORTED OBJECTIVES AND PRIORITIES FOR THE TREATMENT OF SCHIZOPHRENIA IN GERMANY: A MIXED METHODS APPROACH TO CAPTURING THE PATIENT'S PERSPECTIVE
Kinter ET¹, Rudolph I², Schmeding A², Bridges JF¹
¹Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA, ²Janssen-Cilag GmbH, Neuss, Germany

ISPOR Best Paper Poster Research Presentations Awards

	PIN24 ECONOMIC AND CLINICAL IMPACT OF IMPLEMENTATION OF AN ACELLULAR PERTUSSIS VACCINE IN CANADA Iskedjian M¹, Walker J¹, De Serres G², Einarson TR1 ¹PharmIdeas Research and Consulting Inc, Oakville, ON, Canada, ²Université Laval, Québec, QC, Canada
	PMS47 USING HAQ TO ESTIMATE HUI3 AND EQ-5D UTILITY VALUES IN SPANISH RHEUMATOID ARTHRITIS PATIENTS Fernández I¹, Varela C¹, Layola M², Ruiz MD³, Navarro F³ ¹Roche Farma, Madrid, Spain, ²IMS Health, Barcelona, Spain, ³Hospital Universitario Virgen Macarena, Sevilla, Spain
	PSY33 CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH BLOOD TRANSFUSION DURING INPATIENT HOSPITALIZATION: AN ANALYSIS OF THE 2004 HEALTH CARE COST AND UTILIZATION PROJECT NATIONWIDE INPATIENT SAMPLE DATABASE Patel ST¹, Anastassopoulos K¹, Lerner J¹, Ryan K¹, Dodd SL², Goss TF¹, Morton J³ ¹Covance Market Access Services, Gaithersburg, MD, USA, ²Ethicon, Inc, Silesia, MT, USA, ³Stanford University School of Medicine, Stanford, CA, USA

ISPOR Best New Investigator Poster Research Presentations Awards

	PCN6 MODELING LUNG AND BREAST CANCER INCIDENCE IN SPAIN: A ZERO INFLATED NEGATIVE BINOMIAL REGRESSION APPROACH Villa G, Cuervo J, Rebollo P BAP Health Outcomes Research, Oviedo, Asturias, Spain
	PCN21 COST-EFFECTIVENESS OF LAPATINIB PLUS CAPECITABINE FOR WOMEN WITH HER2+ METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH TRATSTUZUMAB IN FINLAND Färkkilä N¹, Torvinen S¹, Bergius S¹, Delea T², Sofrygin O²¹, Walker M³ ¹GlaxoSmithKline Oy, Espoo, Finland, ²Policy Analysis Inc. (PAI), Brookline, MA, USA, ³GlaxoSmithKline, London, UK
	PCN67 COST UTILITY ANALYSIS OF ALEMTUZUMAB COMPARED TO CHLORAMBUCIL IN UNTREATED PATIENTS WITH HIGH-RISK (17P-) CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED KINGDOM Lloyd AC¹, Valderrama A², Ferguson J³, Gilmour L³, Ravndal F¹ ¹IMS, London, UK, ²Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA, ³Bayer Healthcare Pharmaceuticals Inc, Newbury, Berkshire, UK

ISPOR Best Student Poster Research Presentations Awards

	PDB65 A COMPARISON OF DIABETES KNOWLEDGE AMONG RESIDENTS IN BANGKOK AND OTHER CENTRAL PROVINCES OF THAILAND Pongmesa T¹, Li SC², Wee HL¹ ¹National University of Singapore, Singapore, ²University of Newcastle, Callaghan, Australia
	PND3 ANTI-EPILEPTIC MEDICATION DRUG FORMULATION CHANGES AND THEIR RELATIONSHIP TO OUTCOMES (AMBULANCE, EMERGENCY DEPARTMENT AND INPATIENT EVENTS) Mann TA, Rascati KL, Richards KM, Johnsrud M The University of Texas at Austin, Austin, TX, USA
	PSY62 A NATURAL EXPERIMENT TO ESTIMATE THE IMPACT OF A PREFERRED DRUG LIST POLICY FOR LONG ACTING NARCOTIC ANALGESICS ON COSTS AND UTILIZATION Flannagin KR, Martin BC University of Arkansas for Medical Sciences, Little Rock, AR, USA

A special thanks goes to all the judges, the ISPOR Annual European Congress Research Awards Chairs as well as the ISPOR Awards Committee Chair who volunteered their time and efforts in selecting the winners.

ISPOR ANNUAL EUROPEAN CONGRESS RESEARCH AWARDS CHAIRS:

Podium: Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health (UMIT), Adjunct Professor of Health Policy and Management (Harvard School of Public Health); Chair of Department of Public Health, Medical Decision Making and Health Technology; University of Health Sciences, Medical Informatics and Technology; Hall/Innsbruck, Austria

Poster: Evi Hatziandreou MD, DrPH, Director, Health and Healthcare, RAND Europe, Cambridge, UK

ISPOR JUDGES:
Christos Chouaid, Clark Paramore, Carole Coudray Omnes, John Bridges, Carl Asche, Laura McCullagh, Denis Getsios, Brett Hauber, Michael Iskedjian, Gabriela Tannus, Ian Johnson, Katy Slack, Matthew Treaney, Birgitta von Scheele, Lauren Lent, Donald Bushnell, Karen Rascati, Rajesh Balkrishnan, Kristen Migliaccio, Robert Plisko, Deborah Lubeck, Joice Valentim, Ljubica Besker, Hiltrud Liedgens, Mohammad Addollahi, Kirsten Long, Adele Weston, Axel Muhlbacher, Bernard Selke, Sinisa Antolic, Hsing Yi, Matthieu Cuche, Erwin De Cock, Lee Moore, Erna, Ribnicsek, Christel Naujoks, Katalin Rapi, Tony Eti-ukwu, Tipaporn Pongmesa, Michael Minshall, Meir Oren, Nikfar Sheloufeh, Jan Sabo, Beth O'Leary, Zahra Pourmoghaddas, Michael Ganz, Barbara Poulsen-Nautrup, Victoria Brennan, Bradley Martin, Samuel Wagner, Elli Vitsou, Mario Stegert, Siew Hwa Ong, Janneke Grutters, Anna Vavrovsky, Lynda Doward, Hicham Benhaddi, Fleur Levrat, Anne Solesse, Patrick Mollon, Iwona Skrekowska-Baran, Su-Fen Tsai, Chuong Ho, Ahmed Al-Ansi, James Palmer, Yajaira Bastardo, Floortje VanNooten